83
Views
2
CrossRef citations to date
0
Altmetric
Article

Protective Effect of Calcitriol on Organ Damage Induced by 5-Fluorouracil Treatment

, , , , , & ORCID Icon show all
Pages 1687-1696 | Received 30 Jan 2020, Accepted 29 Jul 2020, Published online: 10 Aug 2020

References

  • Grem JL, Chabner BA, Ryan DP, and, Wadlow RC. 5-Fluoropyrimidines. In: Chabner BA, Longo DL editors. Cancer chemotherapy and biotherapy: principles and practice. 5th ed. Philadelphia (PA): Lippincott Williams & Wilkins; 2011. p. 139–170.
  • van Groeningen CJ, Pinedo HM, Heddes J, Kok RM, de Jong AP, Wattel E, Peters GJ, Lankelma J. Pharmacokinetics of 5-fluorouracil assessed with a sensitive mass spectrometric method in patients on a dose escalation schedule. Cancer Res. 1988;48(23):6956–6961.
  • Pinedo HM, Peters GF. Fluorouracil: biochemistry and pharmacology. J Clin Oncol. 1988;6(10):1653–1664. doi:10.1200/JCO.1988.6.10.1653
  • Sommer J, Mahli A, Freese K, Schiergens TS, Kuecuekoktay FS, Teufel A, Thasler WE, Müller M, Bosserhoff AK, Hellerbrand C, et al. Analysis of molecular mechanisms of 5-fluorouracil-induced steatosis and inflammation in vitro and in mice. Oncotarget. 2017;8(8):13059–13072. doi:10.18632/oncotarget.14371
  • Peterson DE, Srivastava R, Lalla RV. Oral mucosal injury in oncology patients: perspectives on maturation of a field. Oral Dis. 2015;21(2):133–141. doi:10.1111/odi.12167
  • Sonis ST. Mucositis: the impact, biology and therapeutic opportunities of oral mucositis. Oral Oncol. 2009;45(12):1015–1020. doi:10.1016/j.oraloncology.2009.08.006
  • Lips P. Vitamin D physiology. Prog Biophys Mol Biol. 2006;92(1):4–8. doi:10.1016/j.pbiomolbio.2006.02.016
  • Glowka E, Stasiak J, Lulek J. Drug delivery systems for vitamin D supplementation and therapy. Pharmaceutics. 2019;11(7):347. doi:10.3390/pharmaceutics11070347
  • Takeuti FAC, Guimaraes FSF, Guimaraes PSF. Applications of vitamin D in sepsis prevention. Discov Med. 2018;25(140):291–297.
  • Szymczak-Pajor I, Śliwińska A. Analysis of association between vitamin D deficiency and insulin resistance. Nutrients. 2019;11(4):794. doi:10.3390/nu11040794
  • Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, Ochoa MT, Schauber J, Wu K, Meinken C, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006;311(5768):1770–1773. doi:10.1126/science.1123933
  • Limketkai BN, Mullin GE, Limsui D, Parian AM. Role of vitamin D in inflammatory bowel disease. Nutr Clin Pract. 2017;32(3):337–345. doi:10.1177/0884533616674492
  • Wang H, Chen W, Li D, Yin X, Zhang X, Olsen N, Zheng SG. Vitamin D and chronic diseases. Aging Dis. 2017;8(3):346–353. doi:10.14336/AD.2016.1021
  • LaRocca CJ, Warner SG. A new role for vitamin d: the enhancement of oncolytic viral therapy in pancreatic cancer. Biomedicines. 2018;6(4):104. doi:10.3390/biomedicines6040104
  • Whitlatch LW, Young MV, Schwartz GG, Flanagan JN, Burnstein KL, Lokeshwar BL, Rich ES, Holick MF, Chen TC. 25-Hydroxyvitamin D-1alpha-hydroxylase activity is diminished in human prostate cancer cells and is enhanced by gene transfer. J Steroid Biochem Mol Biol. 2002;81(2):135–140. doi:10.1016/s0960-0760(02)00053-5
  • Bonovas S, Fiorino G, Lytras T, Malesci A, Danese S. Calcium supplementation for the prevention of colorectal adenomas: a systematic review and meta-analysis of randomized controlled trials. World J Gastroenterol. 2016;22(18):4594–4603. doi:10.3748/wjg.v22.i18.4594
  • Leyssens C, Verlinden L, Verstuyf A. Antineoplastic effects of 1,25(OH)2D3 and its analogs in breast, prostate and colorectal cancer. Endocr Relat Cancer. 2013;20(2):R31–R47. doi:10.1530/ERC-12-0381
  • Feldman D, Krishnan AV, Swami S, Giovannucci E, Feldman BJ. The role of vitamin D in reducing cancer risk and progression. Nat Rev Cancer. 2014;14(5):342–357. doi:10.1038/nrc3691
  • Baron JA, Barry EL, Mott LA, Rees JR, Sandler RS, Snover DC, Bostick RM, Ivanova A, Cole BF, Ahnen DJ, et al. A trial of calcium and vitamin d for the prevention of colorectal adenomas. N Engl J Med. 2015;373(16):1519–1530. doi:10.1056/NEJMoa1500409
  • Barry EL, Peacock JL, Rees JR, Bostick RM, Robertson DJ, Bresalier RS, Baron JA. Vitamin D receptor genotype, vitamin D3 supplementation, and risk of colorectal adenomas: a randomized clinical trial. JAMA Oncol. 2017;3(5):628–635. doi:10.1001/jamaoncol.2016.5917
  • Kovalenko PL, Zhang Z, Cui M, Clinton SK, Fleet JC. 1,25 dihydroxyvitamin D-mediated orchestration of anticancer, transcript-level effects in the immortalized, non-transformed prostate epithelial cell line, RWPE1. BMC Genom. 2010;11:26. doi:10.1186/1471-2164-11-26
  • Vyas D, Laput G, Vyas AK. Chemotherapy-enhanced inflammation may lead to the failure of therapy and metastasis. Onco Targets Ther. 2014;7:1015–1023. doi:10.2147/OTT.S60114
  • Krishnan AV, Feldman D. Mechanisms of the anti-cancer and anti-inflammatory actions of vitamin D. Annu Rev Pharmacol Toxicol. 2011;51:311–336. doi:10.1146/annurev-pharmtox-010510-100611
  • Lee RP, Wang D, Lin NT, Chou YW, Chen HI. A modified technique for tail cuff pressure measurement in unrestrained conscious rats . J Biomed Sci. 2002;9(5):424–427. doi:10.1007/BF02256536
  • Longley DB, Harkin DP, Johnston PG. 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer. 2003;3(5):330–338. doi:10.1038/nrc1074
  • Deboever G, Hiltrop N, Cool M, Lambrecht G. Alternative treatment options in colorectal cancer patients with 5-fluorouracil- or capecitabine-induced cardiotoxicity. Clin Colorect Cancer. 2013;12(1):8–14. doi:10.1016/j.clcc.2012.09.003
  • Lyman GH, Dale DC, Wolff DA, Culakova E, Poniewierski MS, Kuderer NM, Crawford J. Acute myeloid leukemia or myelodysplastic syndrome in randomized controlled clinical trials of cancer chemotherapy with granulocyte colony-stimulating factor: a systematic review. JCO. 2010;28(17):2914–2924. doi:10.1200/JCO.2009.25.8723
  • Cain DW, Cidlowski JA. Immune regulation by glucocorticoids. Nat Rev Immunol. 2017;17(4):233–247. doi:10.1038/nri.2017.1
  • Barnes PJ. Glucocorticoids. Chem Immunol Allergy. 2014;100:311–316. doi:10.1159/000359984
  • Cardoso MM, Leite AO, Santos EA, Gozzani JL, Mathias LA. Effect of dexamethasone on prevention of postoperative nausea, vomiting and pain after caesarean section: a randomised, placebo-controlled, double-blind trial. Eur J Anaesthesiol. 2013;30(3):102–105. doi:10.1097/EJA.0b013e328356676b
  • Hyakuna N, Shimomura Y, Watanabe A, Taga T, Kikuta A, Matsushita T, Kogawa K, Kawakami C, Horikoshi Y, Iwai T, et al. Assessment of corticosteroid-induced osteonecrosis in children undergoing chemotherapy for acute lymphoblastic leukemia: a report from the Japanese Childhood Cancer and Leukemia Study Group. J Pediatr Hematol Oncol. 2014;36(1):22–29. doi:10.1097/MPH.0000000000000039
  • Dhingra AK, Chopra B, Dass R, Mittal SK. An update on anti-inflammatory compounds: a review. Antiinflamm Antiallergy Agents Med Chem. 2015;14(2):81–97. doi:10.2174/1871523014666150514102027
  • Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266–281. doi:10.1056/NEJMra070553
  • Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, Orav JE, Stuck AE, Theiler R, Wong JB, Egli A, Kiel DP, Henschkowski J, et al. Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ. 2009;339(oct01 1):b3692. doi:10.1136/bmj.b3692
  • Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911–1930. doi:10.1210/jc.2011-0385
  • Lee WP, Lin LW, Yeh SH, Liu RH, Tseng CF. Correlations among serum calcium, vitamin D and parathyroid hormone levels in the elderly in southern Taiwan. J Nurs Res. 2002;10:65–72.
  • de la Puente Yagüe M, Collado Yurrita L, Ciudad Cabañas MJ, Cuadrado Cenzual MA. Role of vitamin D in athletes and their performance: current concepts and new trends. Nutrients. 2020;12(2):579. doi:10.3390/nu12020579
  • Garg M, Rosella O, Lubel JS, Gibson PR. Association of circulating vitamin D concentrations with intestinal but not systemic inflammation in inflammatory bowel disease. Inflamm Bowel Dis. 2013;19(12):2634–2643. doi:10.1097/01.MIB.0000436957.77533.b2
  • Gubatan J, Mitsuhashi S, Zenlea T, Rosenberg L, Robson S, Moss AC. Low serum vitamin D during remission increases risk of clinical relapse in patients with ulcerative colitis. Clin Gastroenterol Hepatol. 2017;15(2):240–246. doi:10.1016/j.cgh.2016.05.035
  • Bong AHL, Monteith GR. Calcium signaling and the therapeutic targeting of cancer cells. Biochim Biophys Acta Mol Cell Res. 2018;1865(11 Pt B):1786–1794. doi:10.1016/j.bbamcr.2018.05.015
  • Wu Y, Miyamoto T, Li K, Nakagomi H, Sawada N, Kira S, Kobayashi H, Zakohji H, Tsuchida T, Fukazawa M, et al. Decreased expression of the epithelial Ca2+ channel TRPV5 and TRPV6 in human renal cell carcinoma associated with vitamin D receptor. J Urol. 2011;186(6):2419–2425. doi:10.1016/j.juro.2011.07.086
  • Chen Y, Liu XYu, Zhang F, Liao SFan, He X, Zhuo D, Huang HBin, Wu Y. Vitamin D receptor suppresses proliferation and metastasis in renal cell carcinoma cell lines via regulating the expression of the epithelial Ca2+ channel TRPV5. PLoS One. 2018;13(4):e0195844. doi:10.1371/journal.pone.0195844

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.